Akums Drugs and Pharmaceuticals Share Price: What Could the Next 3 Years Look Like?

The Akums Drugs and Pharmaceuticals share price forecast for the next 3 years is a question on many investors’ minds as the stock trades at Rs 674 on 10 July 2026, within a 52 week range of Rs 409 to Rs 715. This article lays out a scenario based Akums Drugs and Pharmaceuticals share price outlook for 2027, 2028 and 2030, built on the company’s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.

Click Here – Get Free Investment Predictions

Akums Drugs and Pharmaceuticals Company Overview

Akums Drugs and Pharmaceuticals is one of India’s largest contract development and manufacturing organisations for pharmaceuticals, producing formulations for domestic and international pharma companies. Understanding the business model is the first step in framing any credible Akums Drugs and Pharmaceuticals share price forecast, because the durability of earnings ultimately decides where the stock trades.

Company	Akums Drugs and Pharmaceuticals
NSE Ticker	AKUMS
CMP (10 July 2026)	Rs 674
52 Week High	Rs 715
52 Week Low	Rs 409
Market Cap	Rs 10,608 Cr
Stock PE	39.5
Book Value	Rs 211
ROE	8.45%
ROCE	14.9%
Dividend Yield	0.15%

Where Does Akums Drugs and Pharmaceuticals Share Price Stand Today?

The stock currently trades about 6 percent below its 52 week high of Rs 715, which means the market has already tempered some of its optimism. For anyone building a Akums Drugs and Pharmaceuticals share price forecast, this correction matters for the Akums Drugs and Pharmaceuticals share price forecast starting point, because entry valuations have a large bearing on 3 year returns.

At the current price, Akums Drugs and Pharmaceuticals commands a market capitalisation of Rs 10,608 Cr and trades at a price to earnings multiple of 39.5. The company generates a return on equity of 8.45% and a return on capital employed of 14.9%, which places it in the category of businesses with a recovering profitability profile. These numbers anchor the Akums Drugs and Pharmaceuticals share price forecast scenarios that follow. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.

Akums Drugs and Pharmaceuticals Share Price Forecast: Key Growth Drivers for the Next 3 Years

Four forces are likely to shape the Akums Drugs and Pharmaceuticals share price forecast between now and 2030, and together they explain most of the dispersion in this Akums Drugs and Pharmaceuticals share price forecast. Each is discussed below with its likely direction of impact.

Earnings Trajectory and Return Ratios

Stock prices ultimately follow earnings. With a recovering profitability profile at present, the pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Akums Drugs and Pharmaceuticals share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.

Structural Tailwinds in Indian Pharmaceuticals

The Indian pharmaceutical market continues to grow in high single to low double digits, supported by chronic disease prevalence, better diagnosis rates and premiumisation of therapies. Companies with strong brand equity and field force productivity, like Akums Drugs and Pharmaceuticals, are positioned to grow ahead of the market. Sector trends are visible in the Nifty Pharma index, which serves as a useful barometer for the space.

Within the space, investors often benchmark Akums Drugs and Pharmaceuticals against peers such as Piramal Pharma, Onesource Specialty Pharma and Sai Life Sciences on growth and valuations before forming a view on the Akums Drugs and Pharmaceuticals share price forecast.

Company Specific Catalysts

The bull case for Akums Drugs and Pharmaceuticals rests on rising outsourced pharma manufacturing demand from Indian and global pharma companies and capacity expansion. If these play out on schedule, the Akums Drugs and Pharmaceuticals share price forecast for 2030 could gravitate toward the upper end of the scenario range discussed below.

Macro Environment and Liquidity

The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay. A benign macro backdrop supports the optimistic end of any Akums Drugs and Pharmaceuticals share price forecast, while global risk aversion would do the opposite to the Akums Drugs and Pharmaceuticals share price outlook.

Akums Drugs and Pharmaceuticals Share Price Forecast 2027, 2028 and 2030: Scenario Analysis

The table below presents a scenario based Akums Drugs and Pharmaceuticals share price forecast using compounded annual growth assumptions applied to the current market price of Rs 674. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.

Year	Bear Case	Base Case	Bull Case	Assumption
2027	Rs 695	Rs 755	Rs 820	2% to 14% CAGR on CMP
2028	Rs 710	Rs 815	Rs 935	2% to 14% CAGR on CMP
2030	Rs 735	Rs 955	Rs 1,220	2% to 14% CAGR on CMP

In the base case scenario of this Akums Drugs and Pharmaceuticals share price forecast, the 2030 level works out to roughly Rs 955, implying steady compounding from today’s levels. The bull case of Rs 1,220 assumes rising outsourced pharma manufacturing demand from Indian and global pharma companies and capacity expansion delivers ahead of expectations, while the bear case of Rs 735 captures a scenario where growth stalls. That is an outcome band of about 9 percent to 81 percent over the period.

Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast

Bull Case vs Bear Case for Akums Drugs and Pharmaceuticals Share Price

The Bull Case

The optimistic Akums Drugs and Pharmaceuticals share price forecast assumes rising outsourced pharma manufacturing demand from Indian and global pharma companies and capacity expansion. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 1,220 by 2030.

The Bear Case

The cautious view centres on the fact that client concentration among large pharma companies and regulatory compliance across multiple facilities are risks. If these pressures dominate, the Akums Drugs and Pharmaceuticals share price forecast would skew toward the lower band and the stock could stagnate near Rs 735 even by 2030, underperforming broader indices.

Key Risks That Could Change the Akums Drugs and Pharmaceuticals Share Price Outlook

• Execution risk: Delays in strategy execution or capacity plans would push the earnings trajectory below the base case assumed in this Akums Drugs and Pharmaceuticals share price forecast.
• Valuation risk: At a PE of 39.5, any earnings disappointment can trigger sharp multiple compression before fundamentals stabilise.
• Sector risk: Client concentration among large pharma companies and regulatory compliance across multiple facilities are risks.
• Macro risk: A global slowdown, adverse FII flows or unexpected rate moves would compress equity valuations across the market.
• Regulatory risk: Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little warning.

Is Akums Drugs and Pharmaceuticals Worth Watching for the Long Term?

For long term investors, the relevant question is not just where the Akums Drugs and Pharmaceuticals share price forecast lands in 2030 or what any single Akums Drugs and Pharmaceuticals share price forecast says today, but whether the business can compound capital through cycles. The company’s positioning around rising outsourced pharma manufacturing demand from Indian and global pharma companies and capacity expansion gives it a credible growth story, while the risks outlined above define what must be monitored each quarter.

Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Akums Drugs and Pharmaceuticals share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.

Download the Univest iOS App or Univest Android App to track Akums Drugs and Pharmaceuticals share price live.

Conclusion

The Akums Drugs and Pharmaceuticals share price forecast for the next 3 years spans Rs 735 to Rs 1,220 by 2030 under the scenarios discussed, with a base case near Rs 955. Any credible Akums Drugs and Pharmaceuticals share price forecast must be updated as facts change, and the path will be decided by earnings delivery, rising outsourced pharma manufacturing demand from Indian and global pharma companies and capacity expansion and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.

What is the Akums Drugs and Pharmaceuticals share price forecast for the next 3 years?

Ans. The Akums Drugs and Pharmaceuticals share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 735 in the bear case to Rs 1,220 in the bull case, with a base case near Rs 955, depending on earnings delivery and market conditions.

What is the Akums Drugs and Pharmaceuticals share price forecast for 2027?

Ans. For 2027, the scenario range works out to Rs 695 to Rs 820, with a base case around Rs 755. This assumes compounding on the current price of Rs 674 and is illustrative, not a guaranteed outcome.

What is the Akums Drugs and Pharmaceuticals share price forecast for 2028?

Ans. The 2028 scenario range is Rs 710 to Rs 935, with the base case near Rs 815. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.

What is the current share price of Akums Drugs and Pharmaceuticals?

Ans. As of 10 July 2026, Akums Drugs and Pharmaceuticals trades at around Rs 674 on the NSE, within a 52 week range of Rs 409 to Rs 715. Prices change continuously during market hours, so check live quotes before acting.

Is Akums Drugs and Pharmaceuticals a good stock for the long term?

Ans. Akums Drugs and Pharmaceuticals has a credible long term story built on rising outsourced pharma manufacturing demand from Indian and global pharma companies and capacity expansion, but it also carries risks since client concentration among large pharma companies and regulatory compliance across multiple facilities are risks. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.

What is the Akums Drugs and Pharmaceuticals share price outlook for 2030?

Ans. The Akums Drugs and Pharmaceuticals share price outlook for 2030 spans Rs 735 to Rs 1,220 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.

What are the key risks to the Akums Drugs and Pharmaceuticals share price forecast?

Ans. The main risks are execution delays, valuation compression from the current PE of 39.5, sector specific pressures, macro shocks and regulatory changes. Any of these can push the stock below the base case scenario discussed in this article.